Great interview, thanks Bpharma. After all this time with all the associated hiccups and hold ups I must admit I am still holding on and still believe this company has a massive future.Hoping for the day when they can actually sell a therapy commercially but more significantly sell a therapy that answers a huge unmet need.Just the simple idea that an infection caused by many possible different bacteria might be treated with this single compound rather than having to cross match for a specific anti biotic seems life saving.
Good luck to all holders, hopefully current deals can get this over the line.
[INTERVIEW] Recce gearing up for Indonesian trials, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.95M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $12.86K | 42.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17251 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2783 | 3 |
View Market Depth
| Last trade - 12.07pm 17/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |